Gene panel testing for breast cancer should not be used to confirm syndromic gene associations
AffiliationManchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester
MetadataShow full item record
CitationEvans DG, Howell SJ, Frayling IM, Peltonen J. Gene panel testing for breast cancer should not be used to confirm syndromic gene associations. NPJ Genom Med. 2018;3:32.
JournalNPJ Genomic Medicine
- Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory.
- Authors: Gardner SA, Weymouth KS, Kelly WS, Bogdanova E, Chen W, Lupu D, Suhl J, Zeng Q, Geigenmüller U, Boles D, Okamoto PM, McDowell G, Hayden MA, Nagan N
- Issue date: 2018
- A Next Generation Sequencing custom gene panel as first line diagnostic tool for atypical cases of syndromic obesity: Application in a case of Alström syndrome.
- Authors: Maltese PE, Iarossi G, Ziccardi L, Colombo L, Buzzonetti L, Crinò A, Tezzele S, Bertelli M
- Issue date: 2018 Feb
- Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
- Authors: Crawford B, Adams SB, Sittler T, van den Akker J, Chan S, Leitner O, Ryan L, Gil E, van 't Veer L
- Issue date: 2017 Jun
- A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
- Authors: Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J, Brown KL, Sharma L, Saam J, Lancaster J, Daly MB
- Issue date: 2017 May 15
- Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing.
- Authors: Okazaki T, Murata M, Kai M, Adachi K, Nakagawa N, Kasagi N, Matsumura W, Maegaki Y, Nanba E
- Issue date: 2016 Jun